First Time Loading...

Brooks Laboratories Ltd
NSE:BROOKS

Watchlist Manager
Brooks Laboratories Ltd Logo
Brooks Laboratories Ltd
NSE:BROOKS
Watchlist
Price: 108.95 INR 1.97% Market Closed
Updated: Apr 28, 2024

Wall Street
Price Targets

BROOKS Price Targets Summary
Brooks Laboratories Ltd

Wall Street analysts forecast BROOKS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BROOKS is 53 INR .

Lowest
Price Target
Not Available
Average
Price Target
53 INR
51% Downside
Highest
Price Target
Not Available
Brooks Laboratories Ltd Competitors:
Price Targets
CDXS
Codexis Inc
152% Upside
688621
Beijing Sun-Novo Pharmaceutical Research Co Ltd
32% Upside
BANB
Bachem Holding AG
11% Downside
AZTA
Azenta Inc
36% Upside
SYNGENE
Syngene International Ltd
9% Upside
VIMTALABS
Vimta Labs Ltd
37% Upside
GSS
Genetic Signatures Ltd
12% Upside
CSBR
Champions Oncology Inc
22% Upside

Revenue
Forecast

Revenue Estimate
Brooks Laboratories Ltd

For the last 8 years the compound annual growth rate for Brooks Laboratories Ltd's revenue is -4%. The projected CAGR for the next 8 years is 4%.

-4%
Past Growth
4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Brooks Laboratories Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Brooks Laboratories Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BROOKS's stock price target?
Price Target
53 INR

According to Wall Street analysts, the average 1-year price target for BROOKS is 53 INR .

What is Brooks Laboratories Ltd's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Brooks Laboratories Ltd's revenue is -4%. The projected CAGR for the next 8 years is 4%.